Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Zaragoza
Clinical trial register · Spain

Clinical Trials in Zaragoza, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca13 Pfizer11 Universidad de Zaragoza10 AbbVie9 Instituto de Investigación Sanitaria Aragón9
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Zaragoza

260 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Universidad de Zaragoza
Not applicable
108
Zaragoza
2026-12
Not yet open
Assembly Biosciences
Phase 2
80
Zaragoza
2026-10
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Barcelona, Madrid, Girona, Seville, Valencia, Zaragoza
2026-09-29
Recruiting
Exercise and Health Education for Musculoskeletal Health in Industrial Workers
NCT07844707Work-Related Musculoskeletal Disorders
Universidad San Jorge
Not applicable
33
Zaragoza
2026-09-22
Recruiting
Universidad San Jorge
Not applicable
20
Zaragoza
2026-09-21
Recruiting
Hospital Miguel Servet
Not applicable
180
Zaragoza
2026-09-10
Not yet open
Gruppo Oncologico del Nord-Ovest
Phase 3
244
Barcelona, Madrid, Málaga, Ourense, Pamplona, Santander, Valencia, Zaragoza
2026-09-01
Not yet open
Persona Revision Knee System EMEA PMCF Study
NCT07843966Severe Knee Pain, Severe Knee Disability, Revision Arthroplasty
Zimmer, GmbH
Observational
238
Zaragoza
2026-09
Not yet open
iVascular S.L.U.
Not applicable
45
Málaga, Zaragoza, Barcelona, L'Hospitalet de Llobregat, Vigo
2026-08-31
Recruiting
MedSIR
Phase 1/2
278
Badalona, Barakaldo, Barcelona, Madrid, Málaga, San Cristóbal de La Laguna, Seville, Zaragoza
2026-08-20
Active, closed
Instituto de Investigación Sanitaria Aragón
Not applicable
35
Zaragoza
2026-08-03
Recruiting
GlaxoSmithKline
Phase 3
800
BaracaldoVizcaya, Barcelona, Madrid, Seville, Zaragoza
2026-07-27
Not yet open
Nelum Corp
Phase 2
40
Zaragoza, Barcelona, Santander, San Sebastián, Santiago de Compostela, Málaga
2026-07-15
Recruiting
Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using Videoconference
NCT06832605Major Depressive Disorder, Recurrent, in Remission, Major Depressive Disorder, Recurrent, Mild, Major Depressive Disorder, Recurrent, Moderate
Fundació Sant Joan de Déu
Not applicable
342
Elche, Barcelona, Sant Boi de Llobregat, Zaragoza
2026-06-10
Recruiting
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Phase 3
320
Zaragoza, Barcelona, L'Hospitalet de Llobregat, Santander, Granada, Santiago de Compostela, Madrid, Murcia
2026-06-05
Not yet open
RIDECLAS: Delphi Classification of RICA Pathway Recommendations
NCT07615855Enhanced Recovery After Surgery, Perioperative Care, Surgical Care
Universidad de Zaragoza
Observational
384
Zaragoza
2026-06-01
Not yet open
Vall d'Hebron Institute of Oncology
Phase 2
150
Córdoba, Zaragoza, Santander, Barcelona, L'Hospitalet de Llobregat, Sabadell, Lugo, Ourense
2026-06
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07599813Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic
Apollo Therapeutics Ltd
Phase 2
280
Alicante, Badalona, La Paz, Santiago de Compostela, Zaragoza
2026-05-28
Recruiting
AbbVie
Phase 3
990
Barcelona, Córdoba, Madrid, Valencia, Zaragoza
2026-05-22
Active, closed
Personalized Online Occupational Therapy Intervention for Adults With Scleroderma
NCT07661836Scleroderma, Scleroderma (Limited and Diffuse), Systemic Sclerosis (SSc)
Universidad de Zaragoza
Not applicable
24
Zaragoza
2026-05-16
Recruiting
Ipsen
Phase 3
350
Barcelona, Córdoba, Madrid, Pontevedra, Santander, Valencia, Zaragoza
2026-05-14
Recruiting
Regeneron Pharmaceuticals
Phase 2
120
Seville, Barcelona, A Coruña, Pamplona, Madrid, Zaragoza
2026-04-14
Recruiting
A Gaucher Disease Gene Therapy Trial With FLT201
NCT07223944Gaucher Disease Type 1
Spur Therapeutics
Phase 3
45
Barcelona, Zaragoza
2026-04-07
Recruiting
Instituto de Investigación Sanitaria Aragón
Not applicable
12
Zaragoza
2026-04-03
Recruiting
Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort)
NCT07779109SBRT, Radiation Therapy, Endometrial Cancer, Endometrial Cancer Stage III
Instituto de Investigación Sanitaria Aragón
Not applicable
50
Zaragoza
2026-03-30
Recruiting
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
NCT07219459Unresectable or Metastatic Hepatocellular Carcinoma, Child-Pugh A Hepatocellular Carcinoma, Failure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
DrugsVisugromab RDE·Opdivo·Lenvatinib·Nivolumab
CatalYm GmbH
Phase 2
104
Zaragoza, L'Hospitalet de Llobregat, Barcelona, Pamplona, Madrid
2026-03-19
Recruiting
Sanofi
Observational
60
Madrid, Zaragoza
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
850
L'Hospitalet Del Llobregat, Barcelona, Madrid, Valencia, Barakaldo, Málaga, Seville, Zaragoza
2026-03-16
Recruiting
Change in ATOR Screening Test Scores Over 12 Weeks
NCT07497217Achilles Tendinopathy (AT)
Universidad de Zaragoza
Not applicable
40
Zaragoza
2026-02-16
Recruiting
Generate Biomedicines
Phase 3
786
Barcelona, Málaga, Seville, Zaragoza
2026-01-20
Recruiting
Eikon Therapeutics
Phase 1/2
160
Barcelona, Logroño, Madrid, Zaragoza
2026-01-20
By invitation
Clinical Impact of an Anti-Inflammatory Diet in Anxiety and Depression With AI
NCT07398040Depression - Major Depressive Disorder, Anxiety
Universidad de Zaragoza
Not applicable
60
Zaragoza
2026-01-16
Recruiting
Biogen
Phase 2
81
Barcelona, Zaragoza
2026-01-05
Not yet open
Effect of Blood Flow Restriction Rraining on Rehabilitation After Anterior Cruciate Ligament Reconstruction
NCT07311031Anterior Cruciate Ligament Reconstruction Rehabilitation, Blood Flow Restriction (BFR) Training Effects
Hospital MAZ
Not applicable
60
Zaragoza
2025-12-20
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Badalona, Madrid, Murcia, Seville, Valencia, Zaragoza
2025-12-19
Recruiting
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
NCT07209852Bradycardia, Atrioventricular Block, Sinus Node Dysfunction, Bundle-Branch Block
Boston Scientific Corporation
Observational
140
Granada, Zaragoza
2025-12-19
Recruiting
Sanofi
Phase 3
85
Esplugues de Llobregat, Madrid, Zaragoza
2025-12-18
Recruiting
Ascendis Pharma A/S
Phase 3
186
Barcelona, Madrid, Málaga, Zaragoza
2025-12-12
Recruiting
Pharmanutra S.p.a.
Phase 4
146
Barcelona, Málaga, Sant Cugat del Vallès, Zaragoza
2025-12-11
Recruiting
AbbVie
Phase 2/3
490
Santiago de Compostela, Sabadell, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2025-12-10
Recruiting
Janssen Research & Development, LLC
Phase 3
500
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Santiago de Compostela, Valencia, Zaragoza
2025-12-03
Recruiting
GlaxoSmithKline
Phase 3
450
Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza
2025-12-03
Recruiting
Pfizer
Phase 3
500
Santiago de Compostela, Granollers, Zaragoza
2025-12-02
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
153
Córdoba, Santiago de Compostela, Valencia, Valladolid, Zaragoza
2025-12-01
Recruiting
Incyte Corporation
Phase 3
250
Alcorcón, Badalona, Barcelona, Esplugues de Llobregat, Madrid, Zaragoza
2025-11-13
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Barcelona, Madrid, Majadahonda, Málaga, Seville, Valencia, Zaragoza
2025-11-05
Recruiting
AstraZeneca
Phase 3
400
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Zaragoza
2025-10-31
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
NCT06659445Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
DrugAvacincaptad Pegol
ONL Therapeutics
Phase 2
324
Barcelona, Bilbao, Córdoba, Madrid, Seville, Valencia, Zaragoza
2025-10-28
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Barcelona, Madrid, Seville, Zaragoza
2025-10-23
Recruiting
Instituto Oncológico Dr Rosell
Phase 1/2
18
Barcelona, Madrid, Zaragoza
2025-10-22
Recruiting
Jamil Cedeño Mora
Observational
1,200
Terrassa, Getafe, Madrid, Majadahonda, Móstoles, Valencia, Zaragoza
2025-10-01
Not yet open
Instituto de Investigación Sanitaria Aragón
Observational
1,100
Zaragoza
2025-10-01
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Seville, Zaragoza, Burgos, Salamanca, Albacete, Madrid, Oviedo, Valencia
2025-09-26
Recruiting
Sanofi
Phase 3
942
Zaragoza, Badalona, Santander, Barcelona, Madrid
2025-09-17
Recruiting
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Phase 4
50
Barcelona, Madrid, Valencia, Zaragoza
2025-09-17
Recruiting
Alejandro Martín García
Not applicable
30
Zaragoza
2025-09-15
Recruiting
Universidad San Jorge
Not applicable
40
Zaragoza
2025-09-01
Recruiting
BeOne Medicines
Phase 3
351
Barcelona, Pamplona, Valencia, Zaragoza
2025-08-27
Recruiting
Merz Therapeutics GmbH
Phase 3
990
Barcelona, Madrid, Málaga, Seville, Terrassa, Valencia, Vigo, Zaragoza
2025-08-21
Recruiting
Merz Therapeutics GmbH
Phase 3
780
Barcelona, Madrid, Málaga, Seville, Terrassa, Valencia, Vigo, Zaragoza
2025-08-21
Recruiting
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Phase 1
15
Zaragoza, Barcelona, Santander, Córdoba, Donostia / San Sebastian, Madrid, Málaga, Pamplona
2025-08-08
Recruiting
Pfizer
Phase 3
400
A Coruña, Barcelona, Bilbao, Málaga, Granada, Jaén, Zaragoza
2025-08-05
Recruiting
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
80
Seville, Zaragoza, Palma de Mallorca, Burgos, Salamanca, Badalona, Barcelona, Cáceres
2025-08-04
Recruiting
Peer Mentorship Program for Newly Graduated Occupational Therapists in Aragón (MenTOras)
NCT07173283Professional Integration of Newly Graduated Occupational Therapists, Peer Mentorship in Health Professions, Early Career Transition and Professional Identity
Universidad de Zaragoza
Not applicable
40
Zaragoza
2025-08-01
Active, closed
Pfizer
Phase 3
208
Barcelona, Zaragoza
2025-07-31
Recruiting
Óscar Cano Pérez
Not applicable
120
Granada, Zaragoza, Valencia
2025-07-29
Recruiting
Pfizer
Phase 3
150
Santiago de Compostela, Granollers, Zaragoza
2025-07-24
By invitation
Home-Based Closed-Loop Auditory Stimulation to Enhance Slow-Wave Activity in MCI Due to Alzheimer's Disease: A Proof-of-Concept Study
NCT07672977MCI-AD, Early Stage Alzheimer's Disease, Alzheimer s Disease, Mild Cognitive Impairment (MCI) Amnestic, AD
Bitbrain
Not applicable
30
Zaragoza
2025-07-01
Not yet open
Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project
NCT07011368Obesity Prevention, Obesity and Overweight, Obesity and Obesity-related Medical Conditions, Digital Health
Fundació d'investigació Sanitària de les Illes Balears
Not applicable
2,720
Palma de Mallorca, Castelldefels, Zaragoza
2025-07-01
Active, closed
Multicomponent Exercise and Postural Hygiene
NCT07632495Postural Hygiene
Catholic University of Murcia
Not applicable
80
Zaragoza
2025-06-30
Recruiting
Contemplative Practice for Well-being and Self-Deconstruction in Women
NCT06950905Mental Health, Self Concept, Body Dissatisfaction, Compassion
Hospital Miguel Servet
Not applicable
122
Zaragoza
2025-06-18
Recruiting
GlaxoSmithKline
Phase 1/2
451
Barcelona, HebrOn, Madrid, Pamplona, Santander, Zaragoza
2025-06-11
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Salamanca, A Coruña, Barcelona, Málaga, Palma de Mallorca, Zaragoza
2025-05-21
Active, closed
Zura Bio Inc
Phase 2
225
Córdoba, Madrid, Zaragoza
2025-05-16
Recruiting
Hoffmann-La Roche
Phase 3
425
Alcorcón, Majadahonda, Madrid, Zaragoza
2025-05-12
Recruiting
Instituto de Investigación Sanitaria Aragón
Not applicable
90
Zaragoza
2025-05-01
Not yet open
Fundacion Clinic per a la Recerca Biomédica
Phase 1
30
Badalona, Barcelona, L'Hospitalet de Llobregat, Zaragoza
2025-05
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
400
A Coruña, Almería, Barcelona, Madrid, Málaga, Seville, Tarragona, Zaragoza
2025-04-10
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
A Coruña, Barcelona, Madrid, Santiago de Compostela, Seville, Valencia, Zaragoza
2025-04-09
Recruiting
Bristol-Myers Squibb
Phase 3
194
Esplugues de Llobregat, Vigo, Seville, Valencia, Zaragoza
2025-04-08
Recruiting
Hospital Miguel Servet
Not applicable
240
Zaragoza
2025-04-02
Recruiting
Pfizer
Phase 3
674
Santiago de Compostela, Córdoba, Madrid, Zaragoza
2025-04-01
Active, closed
Opioid-Free Anesthesia in Colorectal Surgery, 2025 (OFA-CRC-2025)
NCT07771049Pain Management, Colorectal Surgery, Opioid Free Anesthesia, Postoperative Complications
DrugOpioid-Free Anesthesia
Hospital Universitario La Fe
Phase 1/2
200
Arrecife, Zaragoza
2025-03-15
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
A Coruña, Barcelona, Girona, Madrid, Seville, Valladolid, Zaragoza
2025-03-14
Recruiting
Pfizer
Phase 3
723
Barcelona, Santander, Chiclana de la Frontera, Madrid, Seville, Valladolid, Zaragoza
2025-03-11
Recruiting
The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure
NCT07008365Acute Heart Failure, Congestive Heart Failure, Intraabdominal Hypertension, Cardio-Renal Syndrome
Instituto de Investigación Sanitaria Aragón
Phase 3
168
Zaragoza
2025-03-10
Active, closed
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores, AMR
DrugALXN2030
Alexion Pharmaceuticals, Inc.
Phase 2
47
Barcelona, Zaragoza
2025-03-07
Recruiting
Swedish Orphan Biovitrum
Phase 3
104
A Coruña, Zaragoza
2025-03-06
Recruiting
GlaxoSmithKline
Phase 1/2
305
A Coruña, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2025-03-04
Not yet open
Lucía Pilar Vicente Pina
Not applicable
50
Zaragoza
2025-03
Active, closed
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
NCT06507865Aneurysm, Dissection, Aortic, TAA Thoracoabdominal Aortic Aneurysm, Thoracic Aortic Aneurysm
W.L.Gore & Associates
Observational
155
Zaragoza
2025-02-20
Active, closed
Sanofi
Phase 3
231
Santiago de Compostela, Barcelona, Jerez de la Frontera, Majadahonda, Seville, Sabadell, Zaragoza
2025-02-12
Active, closed
Genmab
Phase 3
584
A Coruña, Donostia / San Sebastian, El Palmar, Madrid, Seville, Valencia, Zaragoza
2025-02-07
Active, closed
Viridian Therapeutics, Inc.
Phase 3
320
A Coruña, Barcelona, Córdoba, Madrid, Navarrés, Seville, Zaragoza
2025-02-03
Recruiting
Effects of GPR with K-Stretch Hammock on Posture and Musculoskeletal Discomfort
NCT06820073Cervical and Lumbar Musculoskeletal Discomfort
Universidad San Jorge
Not applicable
32
Zaragoza
2025-02-01
Recruiting
Santen SAS
Phase 3
234
Granada, Madrid, Santiago de Compostela, Zaragoza
2024-12-30
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Barcelona, Elche, Girona, Madrid, Pamplona, Vigo, Zaragoza
2024-12-13
Active, closed
Hoffmann-La Roche
Phase 3
350
Majadahonda, Zaragoza
2024-12-11
Active, closed
Hoffmann-La Roche
Phase 2
62
L'Hospitalet de Llobregat, Sant Andreu de la Barca, Madrid, Seville, Zaragoza
2024-12-09
Recruiting
Ryvu Therapeutics SA
Phase 2
178
Barcelona, Madrid, Murcia, Pamplona, Salamanca, Seville, Zaragoza
2024-12-05
Active, closed
Biogen
Phase 3
132
Calle Villarroel, Ciutat Vella, Horta-Guinardó, Zaragoza
2024-12-03
Recruiting
Motor Performance Improvement After Visual Rehabilitation
NCT06698172Visual Field Loss, Balance, Brain Injury, Motor Performance
Instituto de Investigación Sanitaria Aragón
Not applicable
30
Zaragoza
2024-11-29
Active, closed
Regeneron Pharmaceuticals
Phase 2
120
Badalona, Santander, Las Palmas de Gran Canaria, Pamplona, Madrid, Seville, Valencia, Zaragoza
2024-11-18
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Córdoba, L'Hospitalet de Llobregat, Terrassa, Burjassot, Barcelona, Seville, Valencia, Zaragoza
2024-10-30
Recruiting
Intra-Cellular Therapies, Inc.
Phase 2
320
Albacete, Badalona, Málaga, Zamora, Zaragoza
2024-10-22
Recruiting
The Sagittarius Trial
NCT06490536Colon Cancer Stage II, Colon Cancer Stage III
DrugsFolinic acid·Panitumumab·Pertuzumab·Temozolomide
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3
700
Barcelona, Valencia, Córdoba, Madrid, Pamplona, Santander, Santiago de Compostela, Zaragoza
2024-10-22
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Zaragoza, Barcelona, Seville, Valencia
2024-10-09
Recruiting
GlaxoSmithKline
Phase 1
845
Badajoz, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2024-09-30
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Majadahonda, Málaga, Lleida, Madrid, Salamanca, Seville, Valladolid, Zaragoza
2024-09-26
Active, closed
Hoffmann-La Roche
Phase 3
338
L'Hospitalet de Llobregat, Seville, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2024-09-23
Recruiting
Sacituzumab govitEcan in THYroid Cancers
NCT06235216Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer
DrugSacituzumab Govitecan
Grupo Espanol de Tumores Neuroendocrinos
Phase 2
42
Barcelona, Ferrol, Hospitalet de Llobregat (Barcelona), Madrid, Murcia, Oviedo, Santander, Zaragoza
2024-09-13
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
130
Seville, A Coruña, El Palmar, Oviedo, Barcelona, Madrid, Valencia, Zaragoza
2024-09-11
Recruiting
Concurrent Training in Patients Undergoing Atrial Fibrillation Ablation.
NCT06832033Atrial Fibrillation (AF), Physical Exercise, Physical Activity, Physical Fitness
Marcos Echevarría
Not applicable
120
Zaragoza
2024-09-09
By invitation
B-challenged: Co-creating Physical and Social Environments to Promote Children's Active Outdoor Play
NCT07136376Active Outdoor Play and Related Healthy Dietary Behaviours
Amsterdam UMC, location VUmc
Not applicable
850
Zaragoza
2024-09-01
Recruiting
Universiteit Antwerpen
Phase 2/3
90
Zaragoza
2024-09-01
Active, closed
argenx
Phase 2
33
Barcelona, Zaragoza
2024-08-30
Active, closed
Viridian Therapeutics, Inc.
Phase 3
132
Santiago de Compostela, Seville, Córdoba, Madrid, Zaragoza
2024-08-27
Active, closed
Viridian Therapeutics, Inc.
Phase 3
204
Santiago de Compostela, Córdoba, Madrid, Seville, Zaragoza
2024-08-27
Recruiting
AbbVie
Phase 3
675
Esplugues de Llobregat, Madrid, Valencia, Zaragoza
2024-08-19
Recruiting
Intra-Cellular Therapies, Inc.
Phase 2
370
Albacete, Zamora, Zaragoza
2024-08-15
Recruiting
AbbVie
Phase 3
110
Ferrol, Esplugues de Llobregat, Málaga, Seville, Zaragoza
2024-08-08
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Burjassot, Barcelona, Santiago de Compostela, Seville, Zaragoza
2024-08-07
Recruiting
Fundación IVI
Observational
1,573
Barcelona, Bilbao, Madrid, Málaga, Seville, Valencia, Vigo, Zaragoza
2024-07-17
Recruiting
Amgen
Phase 3
450
Córdoba, Granada, Málaga, Seville, Zaragoza, Santander, Burgos, Badalona
2024-07-17
Recruiting
Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy
NCT06474819Complete Heart Block, Second Degree Atrioventricular Block Möbitz Type II
Institut d'Investigació Biomèdica de Bellvitge
Not applicable
326
Barcelona, Castellon, Granada, L'Hospitalet de Llobregat, Valencia, Zaragoza
2024-07-12
Active, closed
Exelixis
Phase 2/3
600
A Coruña, Barcelona, Girona, Madrid, Pamplona, Seville, Valencia, Zaragoza
2024-06-07
Recruiting
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Phase 2
51
Zaragoza, Barcelona, L'Hospitalet de Llobregat, Bilbao, Salamanca, Valladolid, Terrassa, Santiago de Compostela
2024-05-16
Active, closed
Spur Therapeutics
Phase 1/2
75
Zaragoza
2024-05-13
Active, closed
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948Atopic Dermatitis
DrugAPG777
Apogee Therapeutics, Inc.
Phase 2
470
Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Alicante, Barcelona, Madrid, Zaragoza
2024-04-29
Recruiting
Universidad de Zaragoza
Not applicable
100
Zaragoza
2024-04-01
Recruiting
Effects of a Computerised Cognitive Stimulation Versus Stimulating Leisure Activities
NCT06058611Mild Cognitive Impairment, Randomized Controlled Trial, Subjective Cognitive Impairment
Universidad de Zaragoza
Not applicable
90
Zaragoza
2024-04-01
Recruiting
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
180
Barcelona, Las Palmas, Madrid, Zaragoza
2024-03-26
Active, closed
AstraZeneca
Phase 2
142
Barakaldo, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia, Zaragoza
2024-02-22
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Málaga, Seville, Zaragoza, Las Palmas de Gran Canaria, Badalona, Barcelona, Santiago de Compostela, Majadahonda
2024-02-20
Active, closed
argenx
Phase 2
103
Badalona, Barcelona, Granada, L'Hospitalet de Llobregat, Valencia, Zaragoza
2024-02-17
Recruiting
Colorado Prevention Center
Phase 3
5,200
Villamartín, Zaragoza, Badalona, Sanlúcar de Barrameda, A Coruña, Santiago de Compostela, Pamplona, Barcelona
2024-01-17
Recruiting
HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population
NCT06993207Dementia, Mild Cognitive Impairment, Dementia Alzheimers, Dementia, Mixed
Bitbrain
Observational
500
Zaragoza
2024-01-15
Active, closed
AbbVie
Phase 2/3
89
Santander, Majadahonda, Barcelona, Córdoba, Madrid, Seville, Zaragoza
2024-01-11
Recruiting
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
NCT07159750Migraine, Episodic Migraine, Chronic Migraine, Headache
Hospital Universitari Vall d'Hebron Research Institute
Observational
700
Badalona, Barcelona, L'Hospitalet de Llobregat, Mollet del Vallès, Viladecans, Albacete, Madrid, Zaragoza
2024-01-02
Recruiting
The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
NCT06685562Breast Cancer Patients, Melanoma Cancer, Prostate Cancer, Supportive Care in Cancer
Leiden University Medical Center
Observational
500
Zaragoza
2023-12-20
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Santiago de Compostela, Zaragoza, Poniente Sur, Santander, Burgos, Ourense, Majadahonda, El Palmar
2023-12-20
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Barcelona, Córdoba, Madrid, Pamplona, Santiago de Compostela, Zaragoza
2023-12-20
Active, closed
AbbVie
Phase 3
614
Badalona, Getafe, Pozuelo de Alarcón, Granada, Madrid, Valencia, Zaragoza
2023-12-19
Recruiting
Ebers Medical Technology, S.L.
Not applicable
100
Zaragoza
2023-12-14
Recruiting
Institut d'Investigació Biomèdica de Bellvitge
Not applicable
90
Sant Joan d'Alacant, Castellon, Vigo, Barcelona, Girona, Santa Cruz de Tenerife, Valencia, Zaragoza
2023-11-22
Recruiting
Amgen
Phase 3
750
Málaga, Seville, Zaragoza, Palma de Mallorca, Las Palmas de Gran Canaria, Santander, Valladolid, Barcelona
2023-11-16
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
756
A Coruña, Barcelona, Jaén, Madrid, San Sebastián, Zaragoza
2023-11-15
Active, closed
Nektar Therapeutics
Phase 2
396
Alicante, Córdoba, Granada, Seville, Zaragoza
2023-11-15
Active, closed
AstraZeneca
Phase 3
1,902
Barcelona, Granada, Hospitalet deLlobregat, Madrid, Santiago de Compostela, Seville, Zaragoza
2023-11-14
Active, closed
GlaxoSmithKline
Phase 2
316
Barcelona, Jaén, Madrid, Pozuelo de AlarcOn Madr, Salamanca, Santander, Valencia, Zaragoza
2023-11-14
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT06128551Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
DrugsElironrasib·Cetuximab
Revolution Medicines, Inc.
Phase 1/2
534
Barcelona, Madrid, Pamplona, Seville, Valencia, Zaragoza
2023-11-14
Active, closed
AbbVie
Phase 2
280
Barcelona, Madrid, Valencia, Zaragoza
2023-11-12
Recruiting
AbbVie
Phase 1
325
Badalona, Pamplona, Barcelona, Madrid, Málaga, Zaragoza
2023-11-09
Active, closed
Pfizer
Phase 3
1,571
Córdoba, Badalona, L'Hospitalet de Llobregat, Santiago de Compostela, Madrid, Barcelona, Valencia, Zaragoza
2023-11-08
Active, closed
Ipsen
Observational
1,057
Badalona, Barcelona, Madrid, Seville, Vigo, Zaragoza
2023-11-01
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Bilbao, Moncloa-Aravaca, Pamplona, Barcelona, Madrid, Salamanca, Valencia, Zaragoza
2023-10-04
Recruiting
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Phase 2
88
Santa Cruz de Tenerife, Barcelona, Donostia / San Sebastian, Madrid, Murcia, Valencia, Zaragoza
2023-09-28
Active, closed
Ad scientiam
Not applicable
336
Girona, Madrid, Málaga, Oviedo, Zaragoza
2023-09-22
Active, closed
AbbVie
Phase 2
130
Santander, Córdoba, Majadahonda, Pamplona, Barcelona, Madrid, Seville, Zaragoza
2023-09-21
Active, closed
PharmaMar
Phase 3
469
A Coruña, Barcelona, Madrid, San Cristóbal de La Laguna, Seville, Valencia, Zaragoza
2023-09-21
Active, closed
Fundació d'investigació Sanitària de les Illes Balears
Phase 3
110
Granada, Palma de Mallorca, Barcelona, Madrid, Murcia, Salamanca, Pontevedra, Zaragoza
2023-09-01
Active, closed
Universidad de Zaragoza
Not applicable
240
Zaragoza
2023-09-01
Active, closed
Peptomyc S.L.
Phase 1
26
Barcelona, L'Hospitalet de Llobregat, Santander, Madrid, Málaga, Zaragoza
2023-08-31
Recruiting
Glaukos Corporation
Phase 2
84
Barcelona, Madrid, Seville, Zaragoza
2023-08-17
Recruiting
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
NCT05999877Chronic Lymphocytic Leukemia
AstraZeneca
Observational
315
Almería, Córdoba, Granada, Jaén, Marbella, Málaga, Seville, Zaragoza
2023-07-11
Active, closed
Cutting Edge SAS
Not applicable
251
Zaragoza
2023-06-21
Recruiting
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
NCT06889883Colorectal Carcinoma, Advanced Adenomas (AA)
ADVANCED MARKER DISCOVERY S.L.
Observational
510
Zaragoza, Bilbao, Donostia / San Sebastian, Santander, Salamanca, Barcelona, Madrid, Oviedo
2023-06-06
Recruiting
A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
NCT05908409Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double Hit Lymphoma, High Grade B-Cell Lymphoma, Not Otherwise Specified
DrugIDP-121
IDP Discovery Pharma S.L.
Phase 1/2
37
Santander, Salamanca, Barcelona, Madrid, Murcia, Seville, Valencia, Zaragoza
2023-06-05
Active, closed
Amgen
Phase 3
509
Málaga, Zaragoza, Barcelona, A Coruña, Majadahonda, Madrid
2023-05-31
Active, closed
Grupo Espanol Multidisciplinario del Cancer Digestivo
Observational
120
Badalona, Terrassa, Madrid, Barcelona, Girona, Valencia, Zaragoza
2023-05-26
Recruiting
Rijnstate Hospital
Not applicable
300
Barcelona, Zaragoza
2023-05-26
Recruiting
IMR-Heart Trasplant Study
NCT06656065Heart Transplant Rejection, Microvascular Resistance
Hospital Miguel Servet
Observational
100
L'Hospitalet de Llobregat, Zaragoza
2023-05-23
Active, closed
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Observational
350
Zaragoza, Donostia / San Sebastian, Santander, Valladolid, Barcelona, Madrid, Valencia
2023-04-26
Active, closed
Whole Body Vibration After Bariatric Surgery
NCT05695599Bariatric Surgery and Whole Body Vibration Training, Bariatric Surgery
Universidad de Zaragoza
Not applicable
28
Zaragoza
2023-04-23
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Donostia / San Sebastian, Zaragoza, Badalona, Barcelona, Córdoba, Girona, Granada, Madrid
2023-04-18
Active, closed
Boston Scientific Corporation
Observational
1,173
Madrid, Pamplona, Valencia, Zaragoza
2023-03-24
Active, closed
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NCT05625958Glaucoma, Open-Angle, Glaucoma, Narrow Angle
Ciliatech
Not applicable
29
Barcelona, Madrid, Sabadell, Zaragoza
2023-03-23
Recruiting
Spanish Oncology Genito-Urinary Group
Phase 2
90
Barcelona, A Coruña, Lugo, Madrid, Toledo, Valencia, Valladolid, Zaragoza
2023-03-07
Active, closed
Hospital Miguel Servet
Not applicable
240
Zaragoza
2023-02-11
Active, closed
Sanofi
Phase 3
91
A Coruña, Zaragoza
2023-02-01
Active, closed
Daiichi Sankyo
Phase 3
1,170
Barcelona, Lleida, Madrid, Málaga, Ourense, Seville, Valenica, Zaragoza
2023-01-11
Recruiting
Registry of the Spanish Society of Thoracic Surgery
NCT05600569Pulmonary Surgical Procedures, Thoracic Surgery, Video-assisted, Robotic Surgical Procedures, Thoracotomy
Sociedad Española de Cirugía Torácica
Observational
30,000
Zaragoza
2023-01-01
Active, closed
Ipsen
Phase 2
68
Barcelona, Madrid, Majadahonda, Pontevedra, Valladolid, Zaragoza
2022-12-29
Active, closed
AstraZeneca
Phase 3
1,350
Las Palmas de Gran Canaria, Lugo, Madrid, Santander, Seville, Valencia, Zaragoza
2022-12-29
Active, closed
Prevail Therapeutics
Phase 1/2
8
Zaragoza
2022-12-20
Active, closed
Amgen
Phase 3
7,297
Córdoba, Málaga, Seville, Zaragoza, León, Badalona, Barcelona, L'Hospitalet de Llobregat
2022-12-14
Recruiting
Pfizer
Phase 3
100
Madrid, Zaragoza
2022-12-09
Active, closed
Mirati Therapeutics Inc.
Phase 2
90
A Coruña, Madrid, Majadahonda, Palma de Mallorca, Seville, Zaragoza
2022-11-22
Active, closed
Almirall, S.A.
Phase 4
447
Barcelona, Granada, Madrid, Salamanca, Seville, Valencia, Zaragoza
2022-10-24
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Barcelona, Ferrol, Girona, Madrid, Majadahonda, Seville, Vigo, Zaragoza
2022-09-27
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Seville, Zaragoza
2022-09-19
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Badalona, Seville, Villajoyosa, Zaragoza
2022-09-13
Active, closed
Exelixis
Phase 3
901
Barcelona, Lleida, Madrid, Valencia, Zaragoza
2022-09-07
Recruiting
GlaxoSmithKline
Phase 3
109
Barcelona, Granada, Madrid, Pozuelo de AlarcOn Madr, Salamanca, Valencia, Zaragoza
2022-09-06
Active, closed
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
NCT05252988Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive
DrugsColesevelam·Loperamide·Neratinib
Spanish Breast Cancer Research Group
Phase 2
177
Elche, Málaga, Zaragoza, L'Hospitalet de Llobregat, Manresa, Mataró, Castellon, Valladolid
2022-08-31
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Barcelona, Madrid, Salamanca, Seville, Valladolid, Zamora, Zaragoza
2022-08-23
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Barcelona, Madrid, Málaga, Pontevedra, Valencia, Zaragoza
2022-08-03
Active, closed
GlaxoSmithKline
Phase 3
163
Barcelona, Granada, Pamplona, Zaragoza
2022-07-14
Active, closed
Pfizer
Phase 2
108
Santiago de Compostela, Barcelona, L'Hospitalet de Llobregat, Madrid, Seville, Valencia, Zaragoza
2022-07-11
Recruiting
Telios Pharma, Inc.
Phase 1/2
70
Lleida, Madrid, Málaga, Zaragoza
2022-06-09
Recruiting
Astellas Pharma Global Development, Inc.
Phase 1
398
Barcelona, El Palmar, Zaragoza
2022-06-07
Recruiting
AB Biotics, SA
Not applicable
120
Zaragoza
2022-06-01
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Barcelona, El Palmar, Madrid, Santiago de Compostela, Seville, Zaragoza
2022-04-14
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Barcelona, Madrid, Valencia, Zaragoza
2022-04-01
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Barcelona, Madrid, Oviedo, Málaga, Valencia, Zaragoza
2022-03-29
Active, closed
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
NCT05477576GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors
DrugsRYZ101·Octreotide·Lanreotide·Sunitinib
RayzeBio, Inc.
Phase 3
343
Barcelona, Madrid, Zaragoza
2022-03-24
Active, closed
Daiichi Sankyo
Phase 3
740
Barcelona, Lleida, Madrid, Málaga, Ourense, Seville, Valencia, Zaragoza
2022-03-04
Recruiting
Instituto de Investigación Sanitaria Aragón
Not applicable
34
Zaragoza
2022-02-28
Active, closed
AstraZeneca
Phase 3
390
Barcelona, Málaga, Valencia, Vigo, Zaragoza
2022-02-21
Active, closed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
NCT05002127Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
DrugsEvorpacept·Ramucirumab·Herceptin·Taxol
ALX Oncology Inc.
Phase 2/3
127
Alicante, Badalona, Barcelona, Córdoba, Lugo, Madrid, Santander, Zaragoza
2022-01-15
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Badajoz, Pozuelo de Alarcón, Oviedo, A Coruña, Barcelona, Madrid, Málaga, Zaragoza
2021-12-17
Recruiting
Takeda
Phase 2
135
Badalona, Barcelona, Madrid, Salamanca, Valencia, Zaragoza
2021-12-16
Recruiting
Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor
NCT05146440Advanced Soft-tissue Sarcoma, Advanced L-sarcomas, Other Advanced Sarcomas, Advanced Solid Tumor
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
195
Zaragoza, Barcelona, Madrid
2021-11-23
Recruiting
Pfizer
Phase 3
245
A Coruña, Barcelona, Madrid, Zaragoza
2021-11-17
Recruiting
Hoffmann-La Roche
Phase 1
542
Donostia / San Sebastian, Majadahonda, Barcelona, Madrid, Valencia, Zaragoza
2021-10-22
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Barcelona, Madrid, Seville, Zaragoza
2021-09-22
Active, closed
Alligator Bioscience AB
Phase 1/2
94
Barcelona, Madrid, Seville, Zaragoza
2021-09-17
Active, closed
Nelum Corp
Phase 1/2
28
Santiago de Compostela, Málaga, Zaragoza, Donostia / San Sebastian, Barcelona, Santander
2021-09-01
Active, closed
Immunome, Inc.
Phase 2/3
198
Barcelona, Madrid, Zaragoza
2021-09-01
Active, closed
HUYABIO International, LLC.
Phase 3
450
Barcelona, Madrid, Málaga, Seville, Zaragoza
2021-08-12
Recruiting
Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
NCT04927156Intracranial Aneurysm, Brain Arterial Disease, Acute Ischemic Stroke, Peripheral Vascular Diseases
Balt Extrusion
Observational
10,000
Madrid, Oviedo, Santander, Zaragoza
2021-07-12
Recruiting
Penumbra Inc.
Observational
1,500
Granada, Zaragoza
2021-06-25
Active, closed
Fertypharm
Not applicable
84
Alicante, Zaragoza
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
557
Palma de Mallorca, Santiago de Compostela, Pamplona/iruña, Córdoba, Madrid, Valencia, Zaragoza
2021-04-26
Active, closed
Geron Corporation
Phase 3
327
Alicante, Badalona, Las Palmas de Gran Canaria, Cáceres, Granada, Madrid, Málaga, Zaragoza
2021-04-12
Recruiting
Boston Scientific Corporation
Observational
12,500
Madrid, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Zaragoza
2021-03-31
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Cáceres, Oviedo, Zaragoza, Badalona, Barcelona, Girona, Las Palmas de Gran Canaria, Lugo
2021-03-11
Recruiting
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NCT04766866Preeclampsia, Intrauterine Growth Restriction, Maternal Hypertension, Neonatal Outcome
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Not applicable
9,132
Badalona, Las Palmas de Gran Canaria, El Palmar, Barcelona, Madrid, Palma de Mallorca, Valencia, Zaragoza
2021-03-02
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Seville, Badalona, Majadahonda, Barcelona, Madrid, Málaga, Zaragoza
2021-02-02
Active, closed
Goat Infant Formula Feeding and Eczema (the GIraFFE Study)
NCT04599946Dermatitis, Atopic, Eczema, Infantile, Infant Development, Child Development
Dairy Goat Co-operative (N.Z.) Limited
Not applicable
2,132
Almería, Granada, Madrid, Reus, Tarragona, Valencia, Zaragoza
2021-01-08
Active, closed
Daiichi Sankyo
Phase 3
605
Barcelona, Madrid, Málaga, Ourense, Seville, Valencia, Zaragoza
2020-12-21
Active, closed
Pfizer
Phase 3
841
Santiago de Compostela, Elche, L'Hospitalet de Llobregat, Barcelona, Madrid, Seville, Valencia, Zaragoza
2020-12-21
Active, closed
AstraZeneca
Phase 3
640
Barcelona, Córdoba, Madrid, Pamplona, Santander, Zaragoza
2020-10-19
Recruiting
University of Birmingham
Phase 1/2
1,672
Barcelona, Bilbao, Madrid, Málaga, Seville, Valencia, Zaragoza
2020-09-17
Recruiting
Mats Heyman
Phase 3
6,430
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Palma de Mallorca, Seville, Valencia, Zaragoza
2020-07-13
Active, closed
Sanofi
Phase 3
337
Barcelona, Pamplona, Valencia, Madrid, Salamanca, Zaragoza
2020-06-16
Active, closed
AstraZeneca
Phase 2
240
Barcelona, Madrid, Seville, Zaragoza
2020-04-22
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Barcelona, L'Hospitalet de Llobregat, Girona, Madrid, Málaga, Pamplona, Zaragoza
2020-02-11
Active, closed
Daiichi Sankyo
Phase 1
115
A Coruña, Barcelona, Las Palmas de Gran Canaria, Madrid, Seville, Zaragoza
2020-02-10
Active, closed
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Observational
1,508
Santiago de Compostela, Pamplona, Barcelona, Córdoba, Granada, Tarragona, Valencia, Zaragoza
2019-05-27
Recruiting
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Observational
1,750
Santiago de Compostela, Córdoba, Granada, Huelva, Málaga, Seville, Huesca, Zaragoza
2019-05-21
Recruiting
Instituto de Investigación Sanitaria Aragón
Phase 2
60
Zaragoza
2019-05-06
Recruiting
RECORDATI GROUP
Observational
95
Barcelona, Bilbao, Madrid, Murcia, Palma de Mallorca, Seville, Zaragoza
2019-01-15
Active, closed
AstraZeneca
Phase 2
367
Córdoba, Donostia / San Sebastian, Madrid, Málaga, Valencia, Zaragoza
2019-01-09
Recruiting
Fundación Academia Española de Dermatología
Observational
2,500
Badalona, Alicante, Barcelona, Las Palmas, Madrid, Pontevedra, Valencia, Zaragoza
2019-01-01
Active, closed
Idorsia Pharmaceuticals Ltd.
Phase 3
107
Barcelona, Madrid, Zaragoza
2018-12-18
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Palma de Mallorca, Sagunto, Barcelona, Madrid, Seville, Valencia, Zaragoza
2018-12-11
Active, closed
AstraZeneca
Phase 3
730
Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza
2018-09-27
Active, closed
Exelixis
Phase 3
837
Santander, Majadahonda, Pamplona, Barcelona, Madrid, Valencia, Zaragoza
2018-06-10
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Barcelona, Madrid, Pamplona, Zaragoza
2018-05-03
Recruiting
Luis A. Moreno Aznar
Not applicable
738
Córdoba, Santiago de Compostela, Zaragoza
2018-03-01
Active, closed
BeiGene
Phase 3
590
Badalona, Barcelona, Madrid, Majadahonda, Pamplona, Valencia, Zaragoza
2017-10-31
Active, closed
Asthma Research in Children and Adolescents
NCT04480242Persistent Asthma, Asthma in Children, Asthma Exacerbation
Parc de Salut Mar
Observational
525
Cadiz, Seville, Zaragoza, Alava, Torrelavega, Barcelona, Madrid, Valencia
2017-07-26
Active, closed
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
NCT02952508Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugCLR 131
Cellectar Biosciences, Inc.
Phase 2
120
Barcelona, Madrid, Salamanca, Zaragoza
2017-07-26
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Barcelona, Málaga, Valencia, Badalona, Castellon, Madrid, Oviedo, Zaragoza
2017-07-21
Active, closed
AstraZeneca
Phase 3
987
A Coruña, Badajoz, Badalona, Barcelona, Madrid, Santander, Valencia, Zaragoza
2017-03-27
Recruiting
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
NCT02275286Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma, Liposarcoma
DrugTrabectedin
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
199
Zaragoza, Barcelona, Palma de Mallorca, San Cristóbal de La Laguna, Madrid, Seville
2014-11
Active, closed
Zimmer POLAR Persona - TKA (EMEA Study)
NCT02337244Severe Knee Pain, Severe Knee Disability, Osteoarthritis, Rheumatoid Arthritis
Zimmer, GmbH
Observational
777
Sabadell, Zaragoza
2013-11-18
Active, closed
AstraZeneca
Phase 3
510
Barcelona, Madrid, Málaga, Seville, Vigo(Pontevedra), Zaragoza
2013-09-25
Active, closed
Genentech, Inc.
Phase 2
378
Elche, Jerez de la Frontera, Donostia / San Sebastian, Barcelona, Cáceres, Lleida, Madrid, Zaragoza
2008-10-16
Rows per page Showing 1–260 of 260
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/zaragoza

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 260 of those studies with a site in Zaragoza.

How many clinical trials are recruiting in Zaragoza?

134 of the 260 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 13 have not yet opened recruitment, 110 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zaragoza), 260 studies
PhaseStudiesRecruitingShare
Phase 3994738.1%
Not applicable472818.1%
Phase 2431616.5%
Observational301911.5%
Phase 1/218136.9%
Phase 1953.5%
Phase 2/3933.5%
Phase 4531.9%

Most active sponsors

Lead sponsors with the most studies (Zaragoza)
Lead sponsorStudiesRecruiting
AstraZeneca133
Pfizer117
Universidad de Zaragoza104
AbbVie95
GlaxoSmithKline96
Instituto de Investigación Sanitaria Aragón97
Hoffmann-La Roche62
Sanofi63
Amgen52
Daiichi Sankyo50
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.